Trial intelligence / Profile preview

Early Calcitonin Therapy for Neuropathic Pain After Spinal Cord Injury

NCT05805683Recruiting

Sponsor
Tanta University
Start
May 2023
Primary completion
May 2027
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in neuropathic pain comparing Calcitonin group with Placebo group (2 arms). Primary endpoints: Intensity of neuropathic pain at 12 months and Incidence of neuropathic pain at 12 months. Started May 2023; status: recruiting.

02

Drugs

TBRIA
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT05805683.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05805683.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call